Treatment for Tamaka shwasa(Bronchial asthma) by panchakarma in Ayurveda.

A Clinical study to Evaluate the effect of Virechana karma on Interleukin(Inflammatory markers) in Tamaka shwasa(Bronchial asthma) A Single Arm Study. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078783

Enrollment

Registered

2024-12-31

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • Chronicity less than 3-5 years. • Mild to moderate grade of Bronchial asthma as per GINA. • The patients having classical signs and symptoms of Tamakaswasa. • PEFR 60% to 90% (Peak Expiratory flow rate). • Patient who are fit for Virechana karma.

Exclusion criteria

Exclusion criteria: The patient with chronic respiratory diseases includes history of Tuberculosis, Pneumonia, Pulmonary effusion. History of cases of COPD. Other complicated respiratory disease having any organic lesion or any anatomical defect in airways. History of Cardiac troubles or any other Pathology. Severe and disoriented asthmatic conditions. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Reduction in the levels of Interleukin 13Timepoint: 30days	—

Secondary

Measure	Time frame
Reduction in the levels of Interleukin 13Timepoint: 30days;Reduction in SymptomsTimepoint: 23days	—

Countries

India

Contacts

Public ContactDR SHRIMANT G CHAVAN

KLEUs Shri B M K Ayurveda Mahavidhyalaya and Researchcentre Shahapur Belgaum Karnataka

pradeepgrampurohit@gmail.com09964144197

Outcome results